Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

Author(s): Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA

Abstract

CD4+CD25+ regulatory T cells contribute to the maintenance of peripheral tolerance by active suppression because their deletion causes spontaneous autoimmune diseases in mice. Human CD4+ regulatory T cells expressing high levels of CD25 are suppressive in vitro and mimic the activity of murine CD4+CD25+ regulatory T cells. Multiple sclerosis (MS) is an inflammatory disease thought to be mediated by T cells recognizing myelin protein peptides. We hypothesized that altered functions of CD4+CD25hi regulatory T cells play a role in the breakdown of immunologic self-tolerance in patients with MS. Here, we report a significant decrease in the effector function of CD4+CD25hi regulatory T cells from peripheral blood of patients with MS as compared with healthy donors. Differences were also apparent in single cell cloning experiments in which the cloning frequency of CD4+CD25hi T cells was significantly reduced in patients as compared with normal controls. These data are the first to demonstrate alterations of CD4+CD25hi regulatory T cell function in patients with MS.

Similar Articles

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

Author(s): Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, et al.

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

Author(s): Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, et al.

Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer

Author(s): Teitelbaum D, Webb C, Bree M, Meshorer A, Arnon R, et al.

The lineage decisions of helper T cells

Author(s): Murphy KM, Reiner SL

Lymphocyte responses and cytokines

Author(s): Paul WE, Seder RA

Mechanisms of action of glatiramer acetate in multiple sclerosis

Author(s): Neuhaus O, Farina C, Wekerle H, Hohlfeld R

Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis

Author(s): Kantengwa S, Weber MS, Juillard C, Benkhoucha M, Fellay B, et al.